Haibing Xiao

Anhui Medical University

Papers

1

Total Citations

6

H-Index

1

About

Haibing Xiao is a pioneering surgeon and clinical researcher whose work centers on the advancement of telesurgery and robotic-assisted surgical systems. His most significant contribution to the field is the landmark multicenter, single-arm, Phase I clinical trial titled "Safety and reliability of telesurgery in China," which provides the first rigorous, evidence-based assessment of remote surgical procedures in a Chinese healthcare setting. This study, published in 2025 and already garnering 6 citations, establishes critical benchmarks for the safety, latency, and reliability of telesurgery, directly addressing the strategic need for expanding surgical robotics infrastructure. By demonstrating that remote operations can be performed with acceptable risk profiles, Xiao’s work lays the foundational clinical framework for broader adoption of telesurgery, particularly in underserved regions. His research not only validates the technical feasibility of long-distance surgical interventions but also highlights the transformative potential of telemedicine in improving healthcare equity. Through this pivotal trial, Haibing Xiao has positioned himself at the forefront of surgical innovation, bridging the gap between robotic engineering and real-world clinical application.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Safety and reliability of telesurgery in China: a multicenter, single-arm, phase I clinical trial
6 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Anhui Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago